Evaluation du site cllsociety.org
CLL Society, the Leading Authority for CLL and SLL Patients
Généré le 20 Mars 2026 07:16
Vieilles statistiques? UPDATE !
Le score est de 54/100
Optimisation du contenu
Titre
CLL Society, the Leading Authority for CLL and SLL Patients
Longueur : 59
Parfait, votre titre contient entre 10 et 70 caractères.
Description
CLL Society is devoted to serving chronic lymphocytic leukemia and small lymphocytic lymphoma cancer patients and caregivers through support and education.
Longueur : 155
Génial, votre balise META description contient entre 70 et 160 caractères.
Mots-clefs
Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.
Propriétés Open Graph
Bien, cette page profite des balises META Open Graph.
| Propriété | Contenu |
|---|---|
| locale | en_US |
| type | website |
| title | Get the Best Care for Your Chronic Lymphocytic Leukemia - CLL Society |
| description | Addressing the unmet needs of the Chronic Lymphocytic Leukemia (CLL) community, our goal is to provide recent and relevant information for CLL patients. |
| url | https://cllsociety.org/ |
| site_name | CLL Society |
| image | https://cllsociety.org/wp-content/uploads/2022/04/CLL-Society-LOGO-w_Tag_Neon_Letter_cropped-300x226-1.png |
| image:width | 300 |
| image:height | 226 |
| image:type | image/png |
Niveaux de titre
| H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | 12 | 6 | 3 | 5 | 0 |
- [H1] Meet our new research grantees
- [H1] WELCOME
- [H2] Actively Enrolling Clinical Trials in CLL
- [H2] Support Our Work
- [H2] Fast Find
- [H2] Newly Diagnosed
- [H2] Testing & Imaging
- [H2] Treatment & Research
- [H2] Medicine Cabinet
- [H2] Support Groups
- [H2] Free CLL Expert Opinion
- [H2] Normal Lab Values & Tracker
- [H2] Ask the Experts
- [H2] What’s New in CLL / SLL?
- [H3] From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health
- [H3] Meet a New More Dangerous Doctor than Dr. Google: AI
- [H3] Golf, 25 Years of CLL, and Long Remissions
- [H3] CLL Patients are Immunocompromised, But What Does That Mean?
- [H3] FDA Approves Combo of Acalabrutinib and Venetoclax in CLL
- [H3] Epcoritamab Combination Therapies for Richter Transformation
- [H4] LIVING WITH CLL
- [H4] TREATMENT & RESEARCH
- [H4] Privacy Overview
- [H5] An investigational CAR-T option
- [H5] Simplify Initiation, Discover More
- [H5] A clinical study for BTK inhibitors resistance
- [H5] A Study of an Investigational Agent in Mature B-Cell Malignancies
- [H5] A Study of an Investigational Agent That Uses a Risk-Guided Approach for Relapsed CLL / SLL
Images
Nous avons trouvé 30 image(s) sur cette page Web.
19 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.
Ratio texte/HTML
Ratio : 4%
le ratio de cette page texte/HTML est au-dessous de 15 pour cent, ce qui signifie que votre site manque de contenu textuel.
Flash
Parfait, aucun contenu FLASH n'a été détecté sur cette page.
Iframe
Dommage, vous avez des Iframes sur vos pages Web, cela signifie que son contenu ne peut pas être indexé par les moteurs de recherche.
Liens
Réécriture d'URLs
Bien. Vos liens sont optimisés!
Tiret bas dans les URLs
Nous avons détectés des soulignements dans vos URLs. Vous devriez plutôt utiliser des tirets pour optimiser votre référencement.
Liens dans la page
Nous avons trouvé un total de 104 lien(s) dont 1 lien(s) vers des fichiers
| Texte d'ancre | Type | Juice |
|---|---|---|
| Skip to content | Interne | Passing Juice |
| HOME | Interne | Passing Juice |
| What’s New | Interne | Passing Juice |
| Info & Mgmt | Interne | Passing Juice |
| Newly Diagnosed | Interne | Passing Juice |
| CLL / SLL Patient Education Toolkit | Interne | Passing Juice |
| Watch and Wait | Interne | Passing Juice |
| Build Your Care Team | Interne | Passing Juice |
| CLL Doctors | Interne | Passing Juice |
| CLL / SLL Symptoms | Interne | Passing Juice |
| Basic Biology of CLL | Interne | Passing Juice |
| Staging | Interne | Passing Juice |
| Complications | Interne | Passing Juice |
| CLL Testing & Imaging | Interne | Passing Juice |
| CLL Diagnosis | Interne | Passing Juice |
| Test Before Treat™ | Interne | Passing Juice |
| Treatment and Research | Interne | Passing Juice |
| Indications for Treatment | Interne | Passing Juice |
| CLL Medicine Cabinet | Interne | Passing Juice |
| Clinical Trials | Interne | Passing Juice |
| Clinical Trial Basics | Interne | Passing Juice |
| Opening Trials & Status Updates | Interne | Passing Juice |
| Clinical Trial Results | Interne | Passing Juice |
| The Patient Perspective | Interne | Passing Juice |
| Targeted Therapies | Interne | Passing Juice |
| Immunotherapy | Interne | Passing Juice |
| Chemotherapy | Interne | Passing Juice |
| CAR-T and Other Cellular Therapies | Interne | Passing Juice |
| Frontline Therapies | Interne | Passing Juice |
| Relapsed/Refractory or Later Therapies | Interne | Passing Juice |
| Richter’s Transformation | Interne | Passing Juice |
| MRD and Disease Monitoring | Interne | Passing Juice |
| CLL / SLL Resources | Interne | Passing Juice |
| Normal CLL Lab Values | Interne | Passing Juice |
| Keeping Track of Lab Results | Interne | Passing Juice |
| CLL Glossary | Interne | Passing Juice |
| CLL Abbreviations & Acronyms | Interne | Passing Juice |
| Ask the Experts | Interne | Passing Juice |
| Health Equity in CLL | Interne | Passing Juice |
| Opinions and Insights | Interne | Passing Juice |
| Regulatory News | Interne | Passing Juice |
| Programs & Support | Interne | Passing Juice |
| Support Groups | Interne | Passing Juice |
| 1-on-1 Support Programs | Interne | Passing Juice |
| Upcoming Events | Interne | Passing Juice |
| Expert Access™ | Interne | Passing Juice |
| Education On-Demand | Interne | Passing Juice |
| CareCast Podcast | Interne | Passing Juice |
| COVID-19 | Interne | Passing Juice |
| COVID-19 Action Plan | Interne | Passing Juice |
| COVID-19 Updates | Interne | Passing Juice |
| COVID-19 Prevention & Treatment | Interne | Passing Juice |
| COVID-19 Official Statements | Interne | Passing Juice |
| COVID-19 Virtual Community Meetings | Interne | Passing Juice |
| COVID-19 General Information | Interne | Passing Juice |
| Living With CLL | Interne | Passing Juice |
| Stories and Testimonials | Interne | Passing Juice |
| Financial Resources | Interne | Passing Juice |
| Insurance Resources | Interne | Passing Juice |
| Mental and Physical Health | Interne | Passing Juice |
| Dr. Koffman’s Blogs | Interne | Passing Juice |
| Creative Corner | Interne | Passing Juice |
| Being Your Own Advocate | Interne | Passing Juice |
| Care Partners | Interne | Passing Juice |
| Veterans | Interne | Passing Juice |
| End of Life Planning | Interne | Passing Juice |
| Surveys | Interne | Passing Juice |
| About Us | Interne | Passing Juice |
| CLL Society in the News | Interne | Passing Juice |
| Our Story, Mission, and Vision | Interne | Passing Juice |
| Scientific Publications | Interne | Passing Juice |
| Board of Directors | Interne | Passing Juice |
| Medical Advisory Board | Interne | Passing Juice |
| Expert Medical Council | Interne | Passing Juice |
| International Partners | Interne | Passing Juice |
| Special Contributors | Interne | Passing Juice |
| Patient Advisory Board | Interne | Passing Juice |
| CLL Society Staff | Interne | Passing Juice |
| Volunteers | Interne | Passing Juice |
| Contact Us | Interne | Passing Juice |
| CLL Society Industry Advisory Council | Interne | Passing Juice |
| Research | Interne | Passing Juice |
| Current Funding Opportunities | Interne | Passing Juice |
| Apply for a Grant | Interne | Passing Juice |
| Eligibility | Interne | Passing Juice |
| Selection and Review Process | Interne | Passing Juice |
| Research Program Guidelines | Interne | Passing Juice |
| What We Fund | Interne | Passing Juice |
| Support Our Efforts | Interne | Passing Juice |
| Advocacy | Interne | Passing Juice |
| Needs of the Immunocompromised | Interne | Passing Juice |
| Access | Interne | Passing Juice |
| Innovation | Interne | Passing Juice |
| Donate | Interne | Passing Juice |
| Community Fundraising | Interne | Passing Juice |
| Celebrating Long Lives 5K Event | Externe | Passing Juice |
| Legacy Giving | Interne | Passing Juice |
| From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health | Interne | Passing Juice |
| Meet a New More Dangerous Doctor than Dr. Google: AI | Interne | Passing Juice |
| Golf, 25 Years of CLL, and Long Remissions | Interne | Passing Juice |
| CLL Patients are Immunocompromised, But What Does That Mean? | Interne | Passing Juice |
| FDA Approves Combo of Acalabrutinib and Venetoclax in CLL | Interne | Passing Juice |
| Epcoritamab Combination Therapies for Richter Transformation | Interne | Passing Juice |
| Site Design | Externe | Passing Juice |
Mots-clefs
Nuage de mots-clefs
clinical cookies sll support resources research treatment covid-19 cll cookie
Cohérence des mots-clefs
| Mot-clef | Contenu | Titre | Mots-clefs | Description | Niveaux de titre |
|---|---|---|---|---|---|
| cll | 106 |  |
 |
|
|
| covid-19 | 28 | |
|
|
|
| cookies | 24 | |
|
|
|
| sll | 22 | |
|
|
|
| research | 22 | |
|
|
|
Ergonomie
Url
Domaine : cllsociety.org
Longueur : 14
Favicon
Génial, votre site web dispose d'un favicon.
Imprimabilité
Aucun style CSS pour optimiser l'impression n'a pu être trouvé.
Langue
Bien. Votre langue est : en.
Dublin Core
Cette page ne profite pas des métadonnées Dublin Core.
Document
Doctype
HTML 5
Encodage
Parfait. Votre charset est UTF-8.
Validité W3C
Erreurs : 0
Avertissements : 0
E-mail confidentialité
Génial, aucune adresse e-mail n'a été trouvé sous forme de texte!
HTML obsolètes
Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.
Astuces vitesse
|
Excellent, votre site n'utilise pas de tableaux imbriqués. |
|
Mauvais, votre site web utilise des styles css inline. |
|
Génial, votre site web contient peu de fichiers CSS. |
|
Mauvais, votre site web contient trop de fichiers javascript (plus de 6). |
|
Parfait : votre site tire parti de gzip. |
Mobile
Optimisation mobile
|
Icône Apple |
|
Méta tags viewport |
|
Contenu FLASH |
Optimisation
Sitemap XML
Votre site web dispose d’une sitemap XML, ce qui est optimal.
| https://cllsociety.org/sitemap_index.xml |
Robots.txt
https://cllsociety.org/robots.txt
Votre site dispose d’un fichier robots.txt, ce qui est optimal.
Mesures d'audience
Votre site web dispose d’une outil d'analytics, ce qui est optimal.
Google Analytics |
PageSpeed Insights
Dispositif
Les catégories
Free SEO Testing Tool
Free SEO Testing Tool est un outil gratuit de référencement qui vous aidera à analyser vos pages web